Biosynex SA (ALBIO.PA)
Paris · EUR · Healthcare · Medical Devices
€0.848 (+7.34%) as of
Key statistics
- Market cap
- 15.63M
- Forward P/E
- 1.84
- EPS (TTM)
- -4.0300
- Dividend yield
- 0.00%
- 52-week range
- 0.4550 – 1.5700
- Beta
- 0.78
- Revenue (TTM)
- 95.19M
- Profit margin
- -61.16%
- Volume
- 26.68k
About Biosynex SA
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products, as well as anti-mosquito bracelets and waterproof, moisturizing, and sensitive skin spray. The company was incorporated in 2005 and is based in Illkirch-Graffenstaden, France.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Illkirch-Graffenstaden, France
- Employees
- 397
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.